Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Steven E. Wilson, MD, received a bachelor’s degree in biology from California State University Fullerton and a master’s degree in molecular biology and biochemistry (Irvine) and an MD (San Diego) from the University of California.
His postgraduate training included an internship in internal medicine at Cedars-Sinai Medical Center in Los Angeles, and residency in ophthalmology at the Mayo Clinic. In addition, Wilson has held faculty positions at the University of Texas Southwestern in Dallas, Cleveland Clinic, and the University of Washington in Seattle, where he was Chair of Ophthalmology and Grace E Hill Professor in Ophthalmology and Biological Structure until 2003. He is currently Staff Refractive and Corneal Surgeon and Director of Corneal Research at the Cole Eye Institute at Cleveland Clinic.
Dr. Wilson has received numerous awards from the medical community, including being listed in "The Best Doctors of America" numerous times. He was an RPB William and Mary Greve International Research Scholar and received the Manpower Award from the Research to Prevent Blindness, a RPB Physician-Scientist Award, the Senior Honor Award from the American Academy of Ophthalmology, and he was elected to the honorary American Ophthalmological Society. He is a diplomat of the American Board of Ophthalmology. Cataract and Refractive Surgery Today named him as one of the 50 most influential doctors in cataract and refractive surgery in May 2006. He received the Lans Distinguished Lecturer Award from the International Society of Refractive Surgery-American Academy of Ophthalmology in 2006.
Wilson has edited many medical journals and papers, held national and international committee responsibilities under the auspices of organizations such as the National Institutes of Health, the Eye Bank Association of America, and Fight for Sight. He is a former trustee and vice president for the Association for Research in Vision and Ophthalmology (ARVO) the largest vision research organization in the world and served on the executive board for ISRS-AAO and is the program chairman for ISRS-AAO for 2006.
Wilson holds various medical patents; is a highly trained and skilled scientist and surgeon; has been awarded numerous research grants in the field of ophthalmology and vision research; and he has authored and presented more than 200 papers, medical books and book chapters. His research focuses on gene delivery to human cells using viral vectors, wound healing, and cytokines and receptors in eye tissues and breast tissues. His laboratory is funded by the National Eye Institute. He is also a leading expert in Dry Eye and Ocular Surface and helped design and implement the phase III clinical trial for topical cyclosporine for dry eye.
Dr. Wilson was selected as a finalist for the Benjamin Franklin Award for 2004 in the category Best New Voice in Fiction for his first international thriller Winter in Kandahar. His second international thriller, Ascent from Darkness, was released September 1, 2007 and was an honoree at the New York Book Festival and Hollywood Book Festival in 2007.
Dr. Wilson's third Novel "The Ghosts of Anatolia: An Epic Journey to Forgiveness: was published in 2010 won the Foreword Reviews Book of the Year Award in Multicultural Fiction in 2010 and won the Runner-up Award for general fiction in the Hollywood Book Festival in 2011.
Laser Refractive Procedures (LASIK/PRK), Refractive Surgery
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 8/17/2016, Dr. Wilson has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.